Key result
The use of a refined microplegia protocol with MiECC during CABG resulted in a nonsignificant median increase in peak hs-cTnT of 35 ng/L compared to OPCAB (95% CI -13 to 84; p=0.16).
Why the study?
The study compared the performance of an institutionally refined microplegia protocol in conjunction with minimal extracorporeal circulation system against off-pump coronary artery bypass grafting.
Does a refined microplegia protocol with MiECC reduce myocardial ischemia parameters compared to OPCAB in patients undergoing isolated CABG?
Cohort (n=278)
No
Does a refined microplegia protocol with MiECC reduce myocardial ischemia parameters compared to OPCAB in patients undergoing isolated CABG?
The use of microplegia with MiECC during CABG results in similar myocardial ischemic injury and MACCE rates compared to OPCAB, while significantly reducing ICU length of stay.
Answers are grounded in this paper and cite their sources.
May support microplegia-MiECC as OPCAB alternative in CABG; leaves open need for RCTs to confirm outcomes.
Background. To compare the performance of our institutionally refined microplegia protocol in conjunction with minimal extracorporeal circulation system (MiECC) with off-pump coronary artery bypass grafting (OPCAB). Methods. We conducted a single center study including patients undergoing isolated CABG surgery performed either off-pump or on-pump using our refined microplegia protocol in conjunction with MiECC. We used propensity modelling to calculate the inverse probability of treatment weights (IPTW). Primary endpoints were peak values of high-sensitivity cardiac troponin T (hs-cTnT) during hospitalization, and respective first values on the first postoperative day. Endpoint analysis was adjusted for intraoperative variables. Results. After IPTW, we could include 278 patients into our analyses, 153 of which had received OPCAB and 125 of which had received microplegia. Standardized differences indicated that treatment groups were comparable after IPTW. The multivariable quantile regression yielded a nonsignificant median increase of first hs-cTnT by 39 ng/L (95% CI -8 to 87 ng/L, p=0.11 ), and of peak hs-cTnT by 35 ng/L (CI -13 to 84, p=0.16 ), when microplegia was used, as compared to OPCAB. Major adverse cardiac and cerebrovascular events (MACCE) occurred with equal frequency in both groups (7.8% vs. 5.0%; p=0.51 ), and length of stay in the intensive care unit (ICU) was significantly shorter after the use of microplegia (geometric mean 1.6 days versus 1.3 days; p=0.01 ). Conclusion. The use of our institutionally refined microplegia in conjunction with MiECC was associated with similar results with regard to ischemic injury, expressed in hs-cTnT compared to OPCAB. MACCE was seen equally frequent. ICU discharge was earlier if microplegia was used.
No takes yet. Share an insight, caveat, or question.
Koechlin et al. (2020) conducted a cohort in Isolated CABG surgery (n=278). Refined microplegia protocol with minimal extracorporeal circulation system (MiECC) vs. Off-pump coronary artery bypass grafting (OPCAB) was evaluated on Peak values of high-sensitivity cardiac troponin T (hs-cTnT) during hospitalization (Median difference 35 ng/L, 95% CI -13 to 84, p=0.16). The use of a refined microplegia protocol with MiECC during CABG resulted in a nonsignificant median increase in peak hs-cTnT of 35 ng/L compared to OPCAB (95% CI -13 to 84; p=0.16).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: